Bangladeshi (DSE) Healthcare Sector Analysis
UpdatedMay 18, 2024
DataAggregated Company Financials
Companies20
- 7D-3.7%
- 3M-16.2%
- 1Y-17.8%
- YTD-16.7%
Over the last 7 days, the Healthcare industry has dropped 3.7%, driven by a pullback from Renata of 7.2%. Meanwhile, Navana Pharmaceuticals actually outperformed within the industry, gaining 7.2% in the last week. The industry has fallen 18% in the last year. Looking forward, earnings are forecast to grow by 18% annually.
Sector Valuation and Performance
Has the Bangladeshi Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 18 May 2024 | ৳457.4b | ৳225.4b | ৳32.8b | 32.2x | 14x | 2x |
| Mon, 15 Apr 2024 | ৳485.1b | ৳220.5b | ৳31.6b | 31x | 15.4x | 2.2x |
| Wed, 13 Mar 2024 | ৳500.3b | ৳220.5b | ৳31.6b | 31.9x | 15.9x | 2.3x |
| Fri, 09 Feb 2024 | ৳548.2b | ৳219.1b | ৳31.5b | 39.9x | 17.4x | 2.5x |
| Sun, 07 Jan 2024 | ৳549.2b | ৳214.4b | ৳31.1b | 28.9x | 17.6x | 2.6x |
| Tue, 05 Dec 2023 | ৳550.8b | ৳216.9b | ৳31.4b | 32.8x | 17.6x | 2.5x |
| Thu, 02 Nov 2023 | ৳552.5b | ৳207.1b | ৳32.1b | 35.5x | 17.2x | 2.7x |
| Sat, 30 Sep 2023 | ৳550.0b | ৳206.7b | ৳32.0b | 36.7x | 17.2x | 2.7x |
| Mon, 28 Aug 2023 | ৳552.4b | ৳206.7b | ৳32.0b | 38x | 17.2x | 2.7x |
| Wed, 26 Jul 2023 | ৳548.8b | ৳206.3b | ৳32.0b | 36.2x | 17.1x | 2.7x |
| Fri, 23 Jun 2023 | ৳549.0b | ৳206.3b | ৳32.0b | 36.8x | 17.1x | 2.7x |
| Sun, 21 May 2023 | ৳545.5b | ৳206.2b | ৳32.2b | 30.3x | 16.9x | 2.6x |
| Tue, 18 Apr 2023 | ৳544.6b | ৳201.5b | ৳33.8b | 28x | 16.1x | 2.7x |
| Thu, 16 Mar 2023 | ৳548.5b | ৳201.5b | ৳33.8b | 27.4x | 16.2x | 2.7x |
| Sat, 11 Feb 2023 | ৳563.7b | ৳198.1b | ৳33.8b | 31.1x | 16.7x | 2.8x |
| Mon, 09 Jan 2023 | ৳554.1b | ৳194.2b | ৳34.3b | 28.1x | 16.1x | 2.9x |
| Wed, 07 Dec 2022 | ৳563.4b | ৳186.0b | ৳34.4b | 27.3x | 16.4x | 3x |
| Fri, 04 Nov 2022 | ৳596.2b | ৳180.0b | ৳35.4b | 26.7x | 16.9x | 3.3x |
| Sun, 02 Oct 2022 | ৳595.2b | ৳177.0b | ৳35.2b | 27.6x | 16.9x | 3.4x |
| Tue, 30 Aug 2022 | ৳557.5b | ৳177.0b | ৳35.2b | 25.8x | 15.8x | 3.1x |
| Thu, 28 Jul 2022 | ৳529.2b | ৳177.0b | ৳35.2b | 24.9x | 15x | 3x |
| Sat, 25 Jun 2022 | ৳552.7b | ৳177.0b | ৳35.2b | 26.7x | 15.7x | 3.1x |
| Mon, 23 May 2022 | ৳549.0b | ৳176.3b | ৳35.1b | 26.4x | 15.6x | 3.1x |
| Wed, 20 Apr 2022 | ৳573.9b | ৳171.6b | ৳34.5b | 24.7x | 16.6x | 3.3x |
| Fri, 18 Mar 2022 | ৳556.0b | ৳171.6b | ৳34.5b | 26.8x | 16.1x | 3.2x |
| Sun, 13 Feb 2022 | ৳580.4b | ৳171.7b | ৳34.5b | 27x | 16.8x | 3.4x |
| Tue, 11 Jan 2022 | ৳558.3b | ৳169.0b | ৳32.7b | 26.9x | 17.1x | 3.3x |
| Thu, 09 Dec 2021 | ৳563.9b | ৳159.3b | ৳30.0b | 28.4x | 18.8x | 3.5x |
| Sat, 06 Nov 2021 | ৳558.7b | ৳149.2b | ৳26.1b | 30.2x | 21.4x | 3.7x |
| Mon, 04 Oct 2021 | ৳601.3b | ৳147.6b | ৳25.5b | 30.4x | 23.6x | 4.1x |
| Wed, 01 Sep 2021 | ৳555.9b | ৳154.0b | ৳25.8b | 28.3x | 21.5x | 3.6x |
| Thu, 08 Jul 2021 | ৳490.9b | ৳154.0b | ৳25.8b | 25.7x | 19x | 3.2x |
Price to Earnings Ratio
18.5x
Current Industry PE
- Investors are pessimistic on the Bangladeshi Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 14.0x which is lower than its 3-year average PE of 17.4x.
- The 3-year average PS ratio of 3.0x is higher than the industry's current PS ratio of 2.0x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 8.3% per year over the last three years.
- Revenues for these companies have grown 14% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Bangladeshi Healthcare sector?
| BD Market | -2.51% | |
| Healthcare | -3.67% | |
| Healthcare Services | 2.03% | |
| Healthtech | 0% | |
| Life Sciences | 0% | |
| Pharma | -3.64% | |
| Biotech | -3.65% | |
| Medical Equipment | -5.16% | |
Industry PE
- Investors are most optimistic about the Biotech industry even though it's trading below its 3-year average PE ratio of 3kx.
- It looks like they are confident that earnings will grow faster in the future than they have historically.
- Investors are most pessimistic about the Pharma industry, which is trading below its 3-year average of 17.0x.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 18% over the next 5 years.
- This is better than its past earnings growth rate of 0.6% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 18% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| NAVANAPHAR Navana Pharmaceuticals | ৳110.70 | 7.2% +৳794.9m | 33.7% | PE27x | |
| ORIONINFU Orion Infusion | ৳634.10 | 1.5% +৳187.3m | 82.5% | PE302.3x | |
| SILVAPHL Silva Pharmaceuticals | ৳16.70 | 2.5% +৳54.6m | -22.7% | PS3.7x | |
| SAMORITA Samorita Hospital | ৳70.40 | 2.0% +৳30.5m | 3.8% | PE126.3x |